Sodium channel blockers in KCNQ2-encephalopathy: Lacosamide as a new treatment option.

doi:10.1016/j.seizure.2017.08.005

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Sodium channel blockers in KCNQ2-encephalopathy: Lacosamide as a new treatment option.

Seizure - 1 Oct 2017

Schubert-Bast Susanne, Hofstetter Peter, Fischer Doris, Schloesser Rolf, Ramantani Georgia, Kieslich Matthias

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetamides
Share to Anticonvulsants
Share to Brain
Share to Brain Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant

Share to KCNQ2 Potassium Channel

Share to Precision Medicine

Share to Sodium Channel Blockers

Source

Open in PubMed

Identifiers

PMID: 28881259
DOI: 10.1016/j.seizure.2017.08.005

Genes

KCNQ2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Sodium channel blockers in KCNQ2-encephalopathy: Lacosamide as a new treatment option.PMID 28881259Read ↗

Recent advances in treatment of epilepsy-related sodium channelopathiesSemantic proximity Read ↗

Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.Semantic proximity Read ↗

Hypertension: CLCN2 chloride channel mutations in primary aldosteronism.Semantic proximity Read ↗

Medicinal chemistry of neuronal voltage-gated sodium channel blockers.Semantic proximity Read ↗

Lacosamide for SCN2A ‐related intractable neonatal and infantile seizuresSemantic proximity Read ↗

Hyperkalemic periodic paralysis aggravated by voltage - gate sodium channel blocker antiepileptic drug?Semantic proximity Read ↗

Ion channels--basic science and clinical disease.Semantic proximity Read ↗

Sodium channels, cardiac arrhythmia, and therapeutic strategy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.